NFKB1 and pancreatic ductal adenocarcinoma: (15) demonstrated that IL-1β secreted from pancreatic ductal adenocarcinoma cells led to aberrant activation of the NF-κB pathway in SCs in the interaction between pancreatic cancer and SCs.